Page last updated: 2024-08-23

idarubicin and Delayed Effects, Prenatal Exposure

idarubicin has been researched along with Delayed Effects, Prenatal Exposure in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Claahsen, HL; Mattijssen, V; Semmekrot, BA; van Dongen, PW1

Other Studies

1 other study(ies) available for idarubicin and Delayed Effects, Prenatal Exposure

ArticleYear
Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report.
    American journal of perinatology, 1998, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Fetal Growth Retardation; Humans; Idarubicin; Infant, Newborn; Infant, Premature; Leukemia, Monocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prenatal Exposure Delayed Effects

1998